Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ahuva Averin"'
Autor:
Lucila Rey-Ares, Ahuva Averin, Nadia Zuccarino, Celina Guadalupe Vega, Emily Kutrieb, Erin Quinn, Mark Atwood, Derek Weycker, Amy W. Law
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 11, Pp 2363-2376 (2024)
Abstract Introduction Lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV) is common among young children in Argentina. Use of the currently available prophylactic agent is limited to children aged ≤ 2 years with selec
Externí odkaz:
https://doaj.org/article/cf0bb7c36d2b4dac99cc407c3ed5eb08
Autor:
Lucila Rey-Ares, Ahuva Averin, Mercedes Mac Mullen, Dhwani Hariharan, Mark Atwood, Carolina Carballo, Liping Huang
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1235-1251 (2024)
Abstract Introduction In Argentina, vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23; PCV13 → PPSV23) has been recommended for all adults aged ≥ 65 years and young
Externí odkaz:
https://doaj.org/article/88b4bd734a474394b793b6771203f1cd
Autor:
Mark H. Rozenbaum, Erica Chilson, Raymond Farkouh, Liping Huang, Alejandro Cane, Adriano Arguedas, Maria J. Tort, Vincenza Snow, Ahuva Averin, Derek Weycker, Dhwani Hariharan, Mark Atwood
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 4, Pp 745-760 (2024)
Abstract Introduction A 20-valent pneumococcal conjugate vaccine (PCV20) was recently recommended for use among US children. We evaluated the cost-effectiveness of PCV20 among children aged 6 years with chronic medical conditions (CMC+) and children
Externí odkaz:
https://doaj.org/article/b712d8278380477ba2012c98d05adfdf
Autor:
Derek Weycker, Ahuva Averin, Linnea Houde, Kevin Ottino, Kimberly Shea, Reiko Sato, Bradford D. Gessner, Kari Yacisin, Daniel Curcio, Elizabeth Begier, Mark Rozenbaum
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 1, Pp 207-220 (2024)
Abstract Introduction While it is widely recognized that older adults, adults with chronic medical conditions (CMC), and adults with immunocompromising conditions (IC) are at increased risk of lower respiratory tract illness (LRTI), evidence of the m
Externí odkaz:
https://doaj.org/article/20f8994f647a4605817553ca7562badb
Publikováno v:
Expert Review of Vaccines, Vol 0, Iss 0 (2023)
Background The Belgian Superior Health Council (SHC) preferentially recommended the 20-valent pneumococcal conjugate vaccine (PCV20) for adults aged ≥65 years, immunocompromised patients, and patients aged ≥50 years suffering from conditions that
Externí odkaz:
https://doaj.org/article/da02285529f54d06838c55ed009d888a
Autor:
Mostafa Zayed, MSc, Jean Joury, BS Pharm, CMD, Mohamed Farghaly, FRCGP, Sara Al Dallal, MD, MSc, Bassam Mahboub, MD, Emily Kutrieb, BA, Ahuva Averin, MPP
Publikováno v:
Current Therapeutic Research, Vol 98, Iss , Pp 100698- (2023)
ABSTRACT: Background: Dubai Health Authority currently recommends sequential administration of 13-valent pneumococcal conjugate vaccine (PCV13) followed by (→) 23-valent pneumococcal polysaccharide vaccine (PPV23) to prevent pneumococcal disease am
Externí odkaz:
https://doaj.org/article/99b16be1e4ac4d40ab5b25668a19bf80
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England
Autor:
Tendai Mugwagwa, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary Slack, Gillian Ellsbury, Diana Mendes
Publikováno v:
Expert Review of Vaccines. 21:1331-1341
Despite use of 23-valent pneumococcal polysaccharide vaccine (PPV23) in England, disease burden among at-risk adults remains high. We evaluated the public health and budgetary impact of 20-valent pneumococcal conjugate vaccine (PCV20) compared to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d713c9afcb44610ec8cd3a782601c52
https://doi.org/10.1080/14760584.2022.2104250
https://doi.org/10.1080/14760584.2022.2104250
Autor:
Mostafa Zayed, Jean Joury, Mohamed Farghaly, Sara Al Dallal, Bassam Mahboub, Emily Kutrieb, Ahuva Averin
Publikováno v:
Curr Ther Res Clin Exp
BACKGROUND: Dubai Health Authority currently recommends sequential administration of 13-valent pneumococcal conjugate vaccine (PCV13) followed by (→) 23-valent pneumococcal polysaccharide vaccine (PPV23) to prevent pneumococcal disease among adults
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d337feeeead5cb15e372844e87b619
https://europepmc.org/articles/PMC10121387/
https://europepmc.org/articles/PMC10121387/
Autor:
Derek Weycker, Ahuva Averin, Linnea Houde, Kevin Ottino, Kimberly M Shea, Bradford J Gessner, Kari Yacisin, Daniel Curcio, Elizabeth Begier, Mark Rozenbaum
Publikováno v:
Open Forum Infectious Diseases. 9
Background While it is widely recognized that older adults and adults with chronic medical conditions are at increased risk of lower respiratory tract infections (LRTI), available evidence on the magnitude of increased risk is limited. Methods A retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c76c5d4afc9f035dec897a28993087
https://doi.org/10.1093/ofid/ofac492.1826
https://doi.org/10.1093/ofid/ofac492.1826
Autor:
Diana Mendes, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary Slack, Gillian Ellsbury, Tendai Mugwagwa
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(8)
Despite the current pneumococcal vaccination program in England for older adults and adults with underlying conditions, disease burden remains high. We evaluated cost-effectiveness of 20-valent pneumococcal conjugate vaccine (PCV20) compared to curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::740db62d60b3ad53dd8228ee8f3dd16c
https://pubmed.ncbi.nlm.nih.gov/36225103
https://pubmed.ncbi.nlm.nih.gov/36225103